COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Biology

Immunology

Medicine

Internal Medicine

Pharmacology

Show all topics

DOI

10.1186/1471-2407-10-464

License

CC-BY

Other Formats

PDF